https://charts.traderzeitung.de/phases/US6024961012
string(1367) "{"isin":"US6024961012","name":"MiMedx Group Inc","stock_id":7874430,"generated_at":"2026-11-04 10:49:00","days":[{"date":"2026-10-30","dst_offset":5,"phases":[{"phase":1,"label":"pre","from":"09:00","to":"14:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"14:30","to":"21:00","close":3.89,"close_at":"2026-10-30 20:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"21:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-11-02","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.275,"close_at":"2026-11-02 21:59:00","complete":true,"perf_pct":-15.8098},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-11-03","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.245,"close_at":"2026-11-03 21:59:00","complete":true,"perf_pct":-0.916},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

array (
  'data' => 
  array (
    'isin' => 'US6024961012',
    'name' => 'MiMedx Group Inc',
    'stock_id' => 7874430,
    'generated_at' => '2026-11-04 10:49:00',
    'days' => 
    array (
      0 => 
      array (
        'date' => '2026-10-30',
        'dst_offset' => 5,
        'phases' => 
        array (
          0 => 
          array (
            'phase' => 1,
            'label' => 'pre',
            'from' => '09:00',
            'to' => '14:30',
            'close' => NULL,
            'close_at' => NULL,
            'complete' => true,
            'perf_pct' => NULL,
          ),
          1 => 
          array (
            'phase' => 2,
            'label' => 'regular',
            'from' => '14:30',
            'to' => '21:00',
            'close' => 3.89,
            'close_at' => '2026-10-30 20:59:00',
            'complete' => true,
            'perf_pct' => NULL,
          ),
          2 => 
          array (
            'phase' => 3,
            'label' => 'post',
            'from' => '21:00',
            'to' => '26:00',
            'close' => NULL,
            'close_at' => NULL,
            'complete' => true,
            'perf_pct' => NULL,
          ),
        ),
      ),
      1 => 
      array (
        'date' => '2026-11-02',
        'dst_offset' => 6,
        'phases' => 
        array (
          0 => 
          array (
            'phase' => 1,
            'label' => 'pre',
            'from' => '10:00',
            'to' => '15:30',
            'close' => NULL,
            'close_at' => NULL,
            'complete' => true,
            'perf_pct' => NULL,
          ),
          1 => 
          array (
            'phase' => 2,
            'label' => 'regular',
            'from' => '15:30',
            'to' => '22:00',
            'close' => 3.275,
            'close_at' => '2026-11-02 21:59:00',
            'complete' => true,
            'perf_pct' => -15.8098,
          ),
          2 => 
          array (
            'phase' => 3,
            'label' => 'post',
            'from' => '22:00',
            'to' => '26:00',
            'close' => NULL,
            'close_at' => NULL,
            'complete' => true,
            'perf_pct' => NULL,
          ),
        ),
      ),
      2 => 
      array (
        'date' => '2026-11-03',
        'dst_offset' => 6,
        'phases' => 
        array (
          0 => 
          array (
            'phase' => 1,
            'label' => 'pre',
            'from' => '10:00',
            'to' => '15:30',
            'close' => NULL,
            'close_at' => NULL,
            'complete' => true,
            'perf_pct' => NULL,
          ),
          1 => 
          array (
            'phase' => 2,
            'label' => 'regular',
            'from' => '15:30',
            'to' => '22:00',
            'close' => 3.245,
            'close_at' => '2026-11-03 21:59:00',
            'complete' => true,
            'perf_pct' => -0.916,
          ),
          2 => 
          array (
            'phase' => 3,
            'label' => 'post',
            'from' => '22:00',
            'to' => '26:00',
            'close' => NULL,
            'close_at' => NULL,
            'complete' => true,
            'perf_pct' => NULL,
          ),
        ),
      ),
    ),
  ),
  'success' => true,
)
MiMedx Group Aktie News & Nachrichten
Trading-Room

MiMedx Group Aktie News & Nachrichten

[WKN: A0MS6X | Symbol: MDXG]
Realtimekurs
   
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

MiMedx Group

MiMedx Inc.: Ersteinschätzung von Citizens JMP zwei Tage vor den Zahlen mit 93 % Kurspotenzial - Steht eine positive Überraschung bevor?

MiMedx Inc. (MDXG) stellt proprietäre Biologika und Hautersatzprodukte zur Behandlung chronischer Wunden...

MiMedx: Biotech-Unternehmen sorgt für immense Einsparpotenziale des US-Gesundheitssystems

Biopharmazeutika gewinnen weltweit an Bedeutung, da sie auf biologischen Materialien basieren und oft...

Profiteur der neuen Medicare-Richtlinien

MiMedx Group ist ein biomedizinisches Unternehmen mit Sitz in Marietta, Georgia. Es hat sich auf die...

Darvas Screening: Freedom Holdings, Lemonade, Palantir, MiMedx Group

Die NEO-DARVAS-STRATEGIE ist ein bemerkenswerter Trendfolgeansatz, der auf einem einfachen, aber wirkungsvollen...

  • ‹
  • 1
  • ›
MiMedx Group Nachrichtenticker öffnen
MT Newswires 23.09.2026 22:54 Uhr

MiMedx meldet günstiges Gerichtsurteil in Axiofill-Klassifizierungsverfahren

04:53 PM EDT, 09/23/2026 (MT Newswires) -- MiMedx (MDXG) teilte am späten Mittwoch mit, dass das US-Bezirksgericht für den nördlichen Distrikt von Geo